Patient Preferences to Value Health Outcomes in Rheumatology Clinical Trials: Report from the OMERACT Special Interest Group

Abstract Objective To inform a research plan for future studies by obtaining stakeholder input on the application of preference-based methods to clinical trial design. Methods We conducted a virtual OMERACT session to encourage stakeholder engagement. We developed materials for the session to facilitate discussion based on identified case examples and feedback sessions. Results Participants prioritized incorporating patient preferences in all aspects of trial design with an emphasis on outcome selection. Participants highlighted the need for careful consideration around preference heterogeneity and equity factors. Conclusion Including patient preferences in trial design was considered a priority requiring further exploration to develop comprehensive guidance.